TY - JOUR
AU - R. Amarasekera
AU - E. Wood
A1 - 
AD - BC Centre on Substance Use, The University of British Columbia, Vancouver, British Columbia, Canada.; BC Centre on Substance Use, The University of British Columbia, Vancouver, British Columbia, Canada bccsu-ew@bccsu.ubc.ca.; Medicine, The University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada.
AN - 37907321
BT - BMJ Case Rep
C5 - Opioids & Substance Use
CP - 10
DA - Oct 31
DO - 10.1136/bcr-2023-255129
DP - NLM
ET - 20231031
IS - 10
JF - BMJ Case Rep
LA - eng
PY - 2023
SN - 1757-790x
ST - Worsening stimulant use disorder outcomes coinciding with off-label antipsychotic prescribing: a commonly unrecognised side effect?
T1 - Worsening stimulant use disorder outcomes coinciding with off-label antipsychotic prescribing: a commonly unrecognised side effect?
T2 - BMJ Case Rep
TI - Worsening stimulant use disorder outcomes coinciding with off-label antipsychotic prescribing: a commonly unrecognised side effect?
U1 - Opioids & Substance Use
U3 - 10.1136/bcr-2023-255129
VL - 16
VO - 1757-790x
Y1 - 2023
ER -